BLACK DIAMOND THERAPEU
3.3202
08-十一月-24 13:50:20
15 分钟延时
股票
+0.1402
+4.41%
今日范围
3.1600 - 3.3800
ISIN
N/A
来源
NASDAQ
-
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
09 11月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
08 11月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
26 10月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Participate in Upcoming Investor Conferences
06 9月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
09 8月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the 2022 Wedbush PacGrow Healthcare Virtual Conference
03 8月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the Jefferies Global Healthcare Conference
06 6月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Appoints Sergey Yurasov, M.D., Ph.D., as Chief Medical Officer
01 6月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Present at the H.C. Wainwright Global Investment Conference
17 5月 2022 07:00:01 条件 Nasdaq GlobeNewswire
-
12 5月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
11 5月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Announces Pipeline Prioritization and Workforce Realignment
25 4月 2022 09:00:00 条件 Nasdaq GlobeNewswire
-
07 4月 2022 16:30:00 条件 Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Appoints Wendy L. Dixon to its Board of Directors
07 4月 2022 07:00:00 条件 Nasdaq GlobeNewswire
-
17 3月 2022 17:00:00 条件 Nasdaq GlobeNewswire
-
Black Diamond Therapeutics to Participate at the Cowen 42nd Annual Health Care Conference
02 3月 2022 08:00:01 条件 Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Appoints Elizabeth Montgomery as Chief People Officer
22 2月 2022 08:00:02 条件 Nasdaq GlobeNewswire
-
Black Diamond Therapeutics Announces Strategic Priorities and Expected Milestones for 2022
10 1月 2022 07:00:02 条件 Nasdaq GlobeNewswire